Finlay, M., Yuan, Z., Morgan, I.M., Campo, M. and Nasir, L. (2012) Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53. Veterinary Research, 43, p. 81. (doi: 10.1186/1297-9716-43-81)
|
Text
76826.pdf - Published Version Available under License Creative Commons Attribution. 1MB |
Abstract
Bovine papillomavirus type 1 infects not only cattle but also equids and is a causative factor in the pathogenesis of commonly occurring equine sarcoid tumours. Whilst treatment of sarcoids is notoriously difficult, cisplatin has been shown to be one of the most effective treatment strategies for sarcoids. In this study we show that in equine fibroblasts, BPV-1 sensitises cells to cisplatin-induced and UVB-induced apoptosis, a known cofactor for papillomavirus associated disease, however BPV-1 transformed fibroblasts show increased clonogenic survival, which may potentially limit the therapeutic effects of repeated cisplatin treatment. Furthermore we show that BPV-1 increases p53 expression in sarcoid cell lines and p53 expression can be either nuclear or cytoplasmic. The mechanism and clinical significance of increase/abnormal p53 expression remains to be established.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Finlay, Ms Margaret and Nasir, Professor Lubna and Morgan, Professor Iain and Yuan, Dr Zhengqiang |
Authors: | Finlay, M., Yuan, Z., Morgan, I.M., Campo, M., and Nasir, L. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine |
Journal Name: | Veterinary Research |
Publisher: | BioMed Central Ltd. |
ISSN: | 0928-4249 |
Copyright Holders: | Copyright © 2012 The Authors |
First Published: | First published in Veterinary Research 43:81 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record